Johnson & Johnson
Report Details
Position on Clinical Trial Data Transparency
At Johnson & Johnson Innovative Medicine (J&J IM), we believe transparency of clinical trial data
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
Report Type
Comprehensive Sustainability Report
Language
English
Year
2024
Format
217.97 MB - PDF
Report Standards:
GRI
ISSB
UN SDG
Similar Reports
(Based on specified tags) Industry / Geography
Report Type
|
2024
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.